natgillin/translations-raw huggingface dataset:
The tablet is placed on the tongue and pressed against the roof of the mouth for around two minutes until it dissolves. 
Tableta se stavi na jezik, pritisne o nepce i tako drži oko dvije minute sve dok se potpuno ne otopi.
The European Medicines Agency decided that Jorveza's benefits are greater than its risks and recommended that it be approved for use in the EU. 
Europska agencija za lijekove zaključila je da koristi od lijeka Jorveza nadmašuju s njim povezane rizike te je preporučila davanje odobrenja za njegovu primjenu u EU-u.
This is a summary of the European public assessment report (EPAR) for Jorveza. 
Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) lijeka Jorveza.
Other information about Jorveza 
Ostale informacije o lijeku Jorveza
It is not intended to provide practical advice on how to use Jorveza. 
Svrha sažetka nije davati praktične savjete o primjeni lijeka Jorveza.
The full EPAR for Jorveza can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports. 
Cjeloviti EPAR za lijek Jorveza nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
What are the risks associated with Jorveza? 
Koji su rizici povezani s lijekom Jorveza?
Side effects with Jorveza are mainly the same as those of other similar medicines. 
Nuspojave lijeka Jorveza uglavnom su iste kao i nuspojave drugih sličnih lijekova.
Jorveza is available as orodispersible tablets (1 mg). 
Lijek Jorveza dostupan je u obliku raspadljivih tableta za usta (1 mg).
Why is Jorveza approved? 
Zašto je lijek Jorveza odobren?
The summary of the opinion of the Committee for Orphan Medicinal Products for Jorveza can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/Rare disease designation. 
Sažetak mišljenja Odbora za lijekove za rijetke bolesti o lijeku Jorveza nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/Rare disease designation.
Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Jorveza have been included in the summary of product characteristics and the package leaflet. 
Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Jorveza nalaze se u sažetku opisa svojstava lijeka i u uputi o lijeku.
Because the number of patients with eosinophilic oesophagitis is low, the disease is considered ‘rare', and Jorveza was designated an ‘orphan medicine' (a medicine used in rare diseases) on 5 August 
Budući da je broj bolesnika s eozinofilnim ezofagitisom nizak, bolest se smatra „rijetkom” te je lijek Jorveza dobio status „lijeka za liječenje rijetkih bolesti” 5. kolovoza 2013.
Corticosteroids help reduce inflammation by attaching to receptors of immune cells and reducing the release of substances that are involved in the inflammation process. 
Kortikosteroidi pomažu pri ublažavanju upale vezivanjem na receptore imunosnih stanica te na taj način smanjuju oslobađanje tvari koje sudjeluju u upalnom procesu.
The most common side effects with Jorveza (which may affect up to 3 in 10 people) are fungal infections in the mouth, pharynx (throat) and oesophagus. 
Najčešće su nuspojave lijeka Jorveza (koje se mogu javiti u do 3 na 10 osoba) gljivične infekcije u ustima, grlu (ždrijelu) ili jednjaku.
The active substance in Jorveza, budesonide, is a corticosteroid medicine. 
Djelatna tvar lijeka Jorveza je budezonid, kortikosteroidni lijek.
For more information about treatment with Jorveza, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist. 
Više informacija o liječenju lijekom Jorveza pročitajte u uputi o lijeku (također dio EPAR-a), odnosno obratite se svojem liječniku ili ljekarniku.
The main measure of effectiveness was the level of eosinophils in the oesophagus and improvement in symptoms. 
Glavna mjera učinkovitosti bila je koncentracije eozinofila u jednjaku i stupanj ublažavanja simptoma.
Jorveza was compared with placebo (a dummy treatment). 
Lijek Jorveza uspoređen je s placebom (prividnim liječenjem).
It is caused by a large build-up of white blood cells called eosinophils in the lining of the oesophagus. 
Uzrokovan je stvaranjem velikog broja bijelih krvnih stanica, tj. eozinofila, u stijenci jednjaka.
Jorveza was shown to be effective in one main study involving 88 adults with eosinophilic oesophagitis. 
Lijek Jorveza pokazao se učinkovitim u jednom glavnom ispitivanju kojim je bilo obuhvaćeno 88 odraslih bolesnika s eozinofilnim ezofagitisom.
For practical information about using Jorveza, patients should read the package leaflet or contact their doctor or pharmacist. 
Praktične informacije o primjeni lijeka Jorveza bolesnici trebaju pročitati u uputi o lijeku, odnosno trebaju se obratiti svojem liječniku ili ljekarniku.
For the full list of all side effects and restrictions with Jorveza, see the package leaflet. 
Potpuni popis svih nuspojava i ograničenja prilikom primjene lijeka Jorveza potražite u uputi o lijeku.
Jorveza benefits patients with eosinophilic oesophagitis by improving the symptoms of the disease and reducing the excess of eosinophils. 
Jorveza koristi bolesnicima s eozinofilnim ezofagitisom jer ublažava simptome bolesti i snižava prekomjerne razine eozinofila.
Jorveza can only be obtained with a prescription and treatment should be started by a doctor experienced with diagnosing and treating eosinophilic oesophagitis. 
Jorveza se izdaje samo na liječnički recept, a liječenje treba započeti liječnik s iskustvom u dijagnosticiranju i liječenju eozinofilnog ezofagitisa.
How is Jorveza used? 
Kako se Jorveza koristi?
How does Jorveza work? 
Kako djeluje Jorveza?
What benefits of Jorveza have been shown in studies? 
Koje su koristi lijeka Jorveza utvrđene u ispitivanjima?
Jorveza contains the active substance budesonide. 
Jorveza sadržava djelatnu tvar budezonid.
Jorveza is a medicine used to treat adults with eosinophilic oesophagitis. 
Jorveza je lijek koji se koristi za liječenje odraslih osoba oboljelih od eozinofilnog ezofagitisa.
During this time the patient should steadily swallow the saliva with the dissolved medicine. 
Dok se tableta raspada, bolesnik treba pomalo gutati slinu s otopljenim lijekom.
Eosinophilic oesophagitis is inflammation of the oesophagus (the food-pipe that leads from the mouth to the stomach), which causes symptoms including dysphagia (difficulty swallowing) and obstruction of the oesophagus. 
Eozinofilni ezofagitis je upala jednjaka (ezofagusa) koja uzrokuje simptome poput disfagije (otežanog gutanja) i začepljenje jednjaka.
After Jorveza dissolves in the mouth, the saliva carries it to the oesophagus where it reduces the inflammation and relieves the symptoms of eosinophilic oesophagitis. 
Nakon što se lijek Jorveza otopi u ustima, slinom se prenosi u jednjak te ublažava upalu i simptome eozinofilnog ezofagitisa.
50000 IU Powder and solvent for solution for injection 
NeoRecormon 50000 IU Prašak i otapalo za otopinu za injekciju
Subcutaneous or intravenous use powder: multidose vial (glass); solvent: ampoule (glass) 
Za primjenu potkožno ili u venu prašak: višedozna bočica (staklo); otapalo: ampula (staklo)
1 vial + 1 ampoule 
1 bočica + 1
solvent: 10 ml (reconst. 
otapalo: 10 ml (rekonst. otopina 5000 IU/ml)
MYLAN SAS 117, allée des Parcs 69800 Saint-Priest France 
Francuska MYLAN SAS 117, allée des Parcs 69800 Saint-Priest France
Oficina D 28230 Las Rozas (Madrid) Spain 
28230 Las Rozas (Madrid) Spain
Germany Hexal Aktiengesellschaft Industriestr. 
Njemačka Hexal Aktiengesellschaft Industriestr.
Desitin Arzneimittel GmbH Postfach 630164 
Norveška Desitin Arzneimittel GmbH Postfach 630164
ARENA GROUP S.A. Str. Ştefan Mihăileanu nr. 
Rumunjska S.C. ARENA GROUP S.A. Str. Ştefan Mihăileanu nr.
Luxembourg Hexal AG Industriestrasse 25 83067 Holzkirchen Germany 
Luksemburg Hexal AG Industriestrasse 25 83067 Holzkirchen Germany
Germany IIP - Institut für industrielle Pharmazie Forschungs- und Entwicklungsgesellschaft mbH 
Njemačka IIP - Institut für industrielle Pharmazie Forschungs- und Entwicklungsgesellschaft mbH
Luxembourg Eurogenerics SA Esplanade Heysel b22 
Luksemburg Eurogenerics SA Esplanade Heysel b22
PSC 170 00 Holesovice Czech Republic 
PSC 170 00 Holesovice Czech Republic magnezijev valproat
Kampenringweg 45 D-E 2803 PE GOUDA The Netherlands 
Kampenringweg 45 D-E 2803 PE GOUDA
110, Esplanade du Général de Gaulle 
Francuska TEVA SANTE 110, Esplanade du Général de Gaulle
Arrow Generiques 26, avenue Tony Garnier 69007 Lyon 
Francuska Arrow Generiques 26, avenue Tony Garnier 69007 Lyon
Laboratoire AGUETTANT 1, rue Alexander Fleming 69007 Lyon 
Francuska Laboratoire AGUETTANT 1, rue Alexander Fleming 69007 Lyon
SANOFI AVENTIS, S.A. Josep Plá, 2 
Španjolska SANOFI AVENTIS, S.A. Josep Plá, 2
Austria sanofi-aventis GmbH SATURN Tower, Vienna DC Leonard-Bernstein-Straße 
Austrija sanofi-aventis GmbH SATURN Tower, Vienna DC Leonard-Bernstein-Straße
Latvia sanofi-aventis Latvia SIA Kr.Valdemara 33-8 Riga LV1010 
Latvija sanofi-aventis Latvia SIA Kr.Valdemara 33-8 Riga LV1010
Luxembourg Takeda Belgium Chaussée de Gand 615 1080 Bruxelles 
Luksemburg Takeda Belgium Chaussée de Gand 615 1080 Bruxelles
Luxembourg Mylan BVBA/SPRL Terhulpsesteenweg 6 box A 1560 Hoeilaart 
Luksemburg Mylan BVBA/SPRL Terhulpsesteenweg 6 box A 1560 Hoeilaart
Evropská 846/176a 160 00 Prague 6 
Sanofi-Aventis, s.r.o. Evropská 846/176a 160 00 Prague 6
Germany 1 A Pharma GmbH Keltenring 1 + 3 
Njemačka 1 A Pharma GmbH Keltenring 1 + 3
Ranbaxy Pharmacie Génériques 
Francuska Ranbaxy Pharmacie Génériques
Luxembourg Sanofi Belgium Leonardo Da Vincilaan 19 1831 Diegem 
Luksemburg Sanofi Belgium Leonardo Da Vincilaan 19 1831 Diegem
D-22311 HAMBURG Deutschland 
D-22311 HAMBURG
Sanofi-Aventis Netherlands B.V. 
Nizozemska Sanofi-Aventis Netherlands B.V.
Germany Sanofi-Aventis Deutschland GmbH 
Njemačka Sanofi-Aventis Deutschland GmbH
Convulsofin Tabletten 
Convulsofin Tabletten tablet
Denmark Sandoz A/S Edvard Thomsens Vej 14 DK-2300 København S Denmark 
Edvard Thomsens Vej 14 DK-2300 København
Germany Stadapharm GmbH Stadastr 2-18 
Njemačka Stadapharm GmbH Stadastr 2-18
Germany Mylan dura GmbH Wittichstr. 
Njemačka Mylan dura GmbH Wittichstr.
Sanofi-Aventis Bulgaria EOOD 
Bugarska Sanofi-Aventis Bulgaria EOOD
Depakine sirop 
Depakine sirup
Via Scarlatti Domenico, 31 20124 Milano Italy 
Via Scarlatti Domenico, 31 20124 Milano Italy valproatna kiselina, natrijev valproat
Sanofi-Aventis zrt. 
Mađarska Sanofi-Aventis zrt.
Germany Dolorgiet GmbH & Co.KG Otto-von-Guericke-Str. 1 
Njemačka Dolorgiet GmbH & Co.KG Otto-von-Guericke-Str.
Orlept (SF) Liquid or Sodium Valproate 40mg/ml oral solution 
Orlept (SF) Liquid or Sodium Valproate 40mg/ml oral solution oralna otopina
Depakine vloeistof voor kinderen, vloeistof voor oraal gebruik 300 mg/ml 
Depakine vloeistof voor kinderen, vloeistof voor oraal gebruik 300 mg/ml oralna tekućina
Syrup 
sirup
Germany Orion Corporation Orionintie 1 A 
Njemačka Orion Corporation Orionintie 1 A
500-1000 mg Modified-release granules 
500-1000 mg granule s prilagođenim oslobađanjem
Germany ALIUD PHARMA GmbH Gottlieb-Daimler-Str. 19 
Njemačka ALIUD PHARMA GmbH Gottlieb-Daimler-Str. 19
LT-09310 Vilnius 
Juozapavičiaus g. 6/2 LT-09310 Vilnius Lithuania
Valproinsäure- ratiopharm Lösung 
Valproinsäure- ratiopharm Lösung oralna otopina
Germany Neuraxpharm Arzneimittel GmbH 
Njemačka Neuraxpharm Arzneimittel GmbH
DEMO ABEE 21st Km Athens-Lamias National Highway 14568 Kryoneri Greece 
National Highway 14568 Kryoneri Greece
Depakine suikervrije stroop, drank 200 mg/5 ml 
Depakine suikervrije stroop, drank 200 mg/5 ml oralna otopina
Sanofi-Aventis Croatia d.o.o. 
Hrvatska Sanofi-Aventis Croatia d.o.o.
Romania Sanofi-Aventis France 1-13 Boulevard Romain Rolland 
Rumunjska Sanofi-Aventis France 1-13 Boulevard Romain Rolland
LABORATOIRES ALTER 3, avenue de la Baltique, ZI de Courtaboeuf 91140 Villebon Sur Yvette France 
Francuska LABORATOIRES ALTER 3, avenue de la Baltique, ZI de Courtaboeuf
DEPAKINE 57,64 mg/ml, sirop 57.64 mg 
DEPAKINE 57,64 mg/ml, sirop 57,64 mg sirup
Valpro TAD Lösung 
Valpro TAD Lösung oralna otopina
17 Bonifraterska Str. 00-203 Warsaw Poland 
Sanofi-Aventis Sp. z o.o. 17 Bonifraterska Str. 00-203 Warsaw Poland
Germany Winthrop Arzneimittel GmbH 
Njemačka Winthrop Arzneimittel GmbH
Germany betapharm Arzneimittel GmbH 
Njemačka betapharm Arzneimittel GmbH
Epilim 100mg Crushable Tablet 
Epilim 100mg Crushable Tablet tableta
1000 Ľubľana Slovenia 
1000 Ljubljana
Epilim 100 mg Crushable Tablets 
Epilim 100 mg Crushable Tablets tableta
VALPROATE DE SODIUM AGUETTANT 400 mg/4 ml, solution injectable 
VALPROATE DE SODIUM AGUETTANT 400 mg/4 ml, solution injectable otopina za injekciju u venu
Modified-release tablet 
tableta s prilagođenim oslobađanjem
Depakine Chronosphere 250 166.76 mg 72.61 mg 
Depakine Chronosphere 250 166,76 mg + 72,61 mg granule s produljenim oslobađanjem
Epilim 400mg Powder & solvent for solution for injection 
Epilim 400mg Powder & solvent for solution for injection prašak za injekciju u venu
Sodium Valproate Oral solution BP 200mg/5ml 
Sodium Valproate Oral solution BP 200mg/5ml oralna otopina
Depakine Chronosphere 750 500,06 mg 217,75 mg 
Depakine Chronosphere 750 500,06 mg + 217,75 mg granule s produljenim oslobađanjem
Convulex 50 mg/ml syrup 50 mg/ml 
Convulex 50 mg/ml syrup 50 mg/ml sirup
Depakine 57,64 mg/ml syrup 57.64 mg/ml 
Depakine 57,64 mg/ml syrup 57,64 mg/ml sirup
Sodium valproate liquid 200mg/5ml 
Sodium valproate liquid 200mg/5ml oralna otopina
Depakine Chronosphere 100 66,66 mg 29.03 mg 
Depakine Chronosphere 100 66,66 mg + 29,03 mg granule s produljenim oslobađanjem
Depakine Enteric 150 mg 150 mg 
Depakine Enteric 150 mg 150 mg tablet
Depakine Chronosphere 1000 666,60 mg 290.27 mg 
Depakine Chronosphere 1000 666,60 mg + 290,27 mg granule s produljenim oslobađanjem
Depakine Chrono 500, tabletten met gereguleerde afgifte 500 mg 
Depakine Chrono 500, tabletten met gereguleerde afgifte 500 mg tableta s prilagođenim oslobađanjem
Magnesium Valproate 
Italy magnezijev valproat
Romania Desitin Arzneimittel Gmbh Weg beim Jaeger 214 
Rumunjska Desitin Arzneimittel Gmbh Weg beim Jaeger 214
Natriumvalproaat Apotex 300 mg/5 ml, drank 
Natriumvalproaat Apotex 300 mg/5 ml, drank oralna otopina
Convulex 100 mg/ml solution for injection/concentrate for solution for infusion 
Convulex 100 mg/ml solution for injection/concentrate for solution for infusion otopina za injekciju/infuziju u venu
Depakine Chrono 300, tabletten met gereguleerde afgifte 300 mg 
Depakine Chrono 300, tabletten met gereguleerde afgifte 300 mg tableta s prilagođenim oslobađanjem
Prolonged-release capsule 
kapsula s produljenim oslobađanjem
Modified-release capsule, hard 
kapsula s produljenim oslobađanjem, tvrda
13435 Berlin espa-valept 300 mg retard 199.8 mg, 87 mg 
Germany espa-valept 300 mg retard 199,8 mg, 87 mg
Valpromide Depamide 300 mg comprimidos gastrorresistentes 
Spain valpromid Depamide 300 mg comprimidos gastrorresistentes
Valproat HEXAL 300mg/ml Lösung 
Valproat HEXAL 300mg/ml Lösung oralna otopina
Germany Desitin Arzneimittel Gmbh Weg beim Jaeger 214 
Njemačka Desitin Arzneimittel Gmbh Weg beim Jaeger 214
DEPAKINE CHRONO (SPHERE) 1000 mg/sachet Coated granules in sachet 
DEPAKINE CHRONO (SPHERE) 1000 mg/vrećica obložene granule u vrećici
Germany TAD Pharma GmbH Heinz-Lohmann-Str. 5 
Njemačka TAD Pharma GmbH Heinz-Lohmann-Str.
Sodium valproate 100mg/ml solution for injection or infusion 
Sodium valproate 100mg/ml solution for injection or infusion otopina za injekciju/infuziju u venu
Depakine Chronosphere 500 333.30 mg 145,14 mg 
Depakine Chronosphere 500 333,30 mg + 145,14 mg granule s produljenim oslobađanjem
Depakine 300 mg/ml Tropfen 300 mg/ml 
Depakine 300 mg/ml Tropfen 300 mg/ml oralna otopina
Valproic acid Convulex gelule gastro résistante 
Convulex gelule gastro résistante želučanootporna kapsula
Episenta solution for injection 100 mg/ml 
Episenta solution for injection 100 mg/ml otopina za injekciju u venu
Valpromide DEPAMIDE 300 mg, comprimé pelliculé gastro-résistant 
France valpromid DEPAMIDE 300 mg, comprimé pelliculé gastro-résistant
Germany AbZ-Pharma GmbH Graf-Arco-Str. 3 
Njemačka AbZ-Pharma GmbH Graf-Arco-Str.
Depakine 300 mg/5 ml 
Depakine 300 mg/5 ml sirup
Orfiril CR 1000 mg, granulaat met gereguleerde afgifte 
Orfiril CR 1000 mg, granulaat met gereguleerde afgifte granule s prilagođenim oslobađanjem
Convulex 300 mg/ml oral solution 
Convulex 300 mg/ml oral solution oralna otopina
Depakine 100 mg/ml polvo y disolvente para solución inyectable 
Depakine 100 mg/ml polvo y disolvente para solución inyectable prašak i otapalo za otopinu za injekciju u venu
Germany Ratiopharm GmbH Graf-Arco-Strasse 3 
Njemačka Ratiopharm GmbH Graf-Arco-Strasse 3
Sanofi-Aventis SpA Viale Luigi Bodio, 37/B 20158 Milano Italy 
Sanofi-Aventis SpA Viale Luigi Bodio, 37/B 20158 Milano Italy valpromid Depamide
Orfiril CR 500 mg, granulaat met gereguleerde afgifte 
Orfiril CR 500 mg, granulaat met gereguleerde afgifte granule s prilagođenim oslobađanjem
EG LABO - Laboratoires EuroGenerics "Le Quintet" - bâtiment A 12, rue Danjou 92517 Boulogne Billancourt Cedex 
92517 Boulogne Billancourt Cedex
VALPROATE DE SODIUM ARROW 200 mg/ml, solution buvable 
VALPROATE DE SODIUM ARROW 200 mg/ml, solution buvable oralna otopina
Convulex 300 mg/ml - Lösung zum Einnehmen 
Convulex 300 mg/ml - Lösung zum Einnehmen oralna otopina
Orfiril Injektionslösung 
Orfiril Injektionslösung otopina za injekciju u venu
Depakine Enteric 300 mg 300 mg 
Depakine Enteric 300 mg 300 mg tablet
VALPROATE DE SODIUM ZENTIVA 200 mg/ml, solution buvable 
VALPROATE DE SODIUM ZENTIVA 200 mg/ml, solution buvable oralna otopina
Orfiril 100 mg/ml, oplossing voor injectie 
Orfiril 100 mg/ml, oplossing voor injectie otopina za injekciju u venu
DEPAKINE CHRONO 300 mg filmom obložene tablete 
DEPAKINE CHRONO 300 mg filmtabletta filmom obložena tableta
Episenta 150mg Prolongedrelease capsules 
Episenta 150mg Prolongedrelease capsules kapsula s produljenim oslobađanjem
Prolonged-release capsule, hard 
Orfiril long kapsula s produljenim oslobađanjem, tvrda
Solution for injection/concentra te for solution for infusion 
otopina za injekciju/ koncentrat za otopinu za infuziju u venu
DEPAKINE CHRONO 500 mg filmom obložene tablete 
DEPAKINE CHRONO 500 mg filmtabletta filmom obložena tableta
Convulex Tropflösung 
Convulex Tropflösung oralna otopina
DEPAKINE 200 mg/ml, solution buvable 
DEPAKINE 200 mg/ml, solution buvable oralna otopina
Episenta 300mg Prolongedrelease capsules 
Episenta 300mg Prolongedrelease capsules kapsula s produljenim oslobađanjem
Valproic acid Convulex 50 mg/ml - Sirup für Kinder 
Convulex 50 mg/ml - Sirup für Kinder sirup
Natriumvalproat G.L. 
VALPROATE DE SODIUM GNR L.P.
Depakine 200 mg/ml solución oral 
Depakine 200 mg/ml solución oral oralna otopina
13435 Berlin espa-valept 500 mg retard 333 mg, 145 mg 
Germany espa-valept 500 mg retard 333 mg, 145 mg
Valproic acid CONVULEX 50 mg/ml szirup gyermekeknek 
CONVULEX 50 mg/ml szirup gyermekeknek sirup
Germany TEVA GmbH Graf-Arco-Str. 3 
Njemačka TEVA GmbH Graf-Arco-Str.
Valproic acid ORFIRIL SAFT 
Orfiril Saft oralna otopina
Orfiril CR 300 mg, capsules met gereguleerde afgifte 
Orfiril CR 300 mg, capsules met gereguleerde afgifte kapsula s prilagođenim oslobađanjem, tvrda
Orfiril CR 150 mg, capsules met gereguleerde afgifte 
Orfiril CR 150 mg, capsules met gereguleerde afgifte kapsula s prilagođenim oslobađanjem, tvrda
Valproic acid DEPAKINE 50 mg/ml szirup 50 mg/ml 
DEPAKINE 50 mg/ml szirup 50 mg/ml sirup
Valproát chrono Sandoz 500 mg tablety s predľženým uvoľňovaním 
Valproát chrono Sandoz 500 mg tablety s predľženým uvoľňovaním tableta s prilagođenim oslobađanjem
Ireland Sanofi-aventis Ireland Ltd. T/A SANOFI 
Sanofi-aventis Ireland Ltd.
104 25 Stockholm Sweden 
104 25 Stockholm Sweden valproatna kiselina natrijev valproat
Valproát chrono Sandoz 300 mg tablety s predľženým uvoľňovaním 
Valproát chrono Sandoz 300 mg tablety s predľženým uvoľňovaním tableta s prilagođenim oslobađanjem
Depakine Enteric 500 mg 500 mg 
Depakine Enteric 500 mg 500 mg tablet
Epilim Syrup 200mg/5ml 
Epilim Syrup 200mg/5ml oralna otopina
Depakine Chronosphere 1000 mg, granulaat met gereguleerde afgifte 
Depakine Chronosphere 1000 mg, granulaat met gereguleerde afgifte granule s prilagođenim oslobađanjem
Valproid acid, Sodium valproate 
valproatna kiselina, natrijev valproat
Depakine Chronosphere 750 mg, granulaat met gereguleerde afgifte 
Depakine Chronosphere 750 mg, granulaat met gereguleerde afgifte granule s prilagođenim oslobađanjem
Solution for injection 
otopina za injekciju u venu
Convulex 300 mg/ml kvapky 300mg/ml 
CONVULEX 300 mg/ML
Valproic acid Convulex 150 mg kapsuly 
Convulex 150 mg kapsuly kapsula
Ergenyl Chronosphere 1000 mg Retardgranulat 
Ergenyl Chronosphere 1000 mg Retardgranulat granule s produljenim oslobađanjem
Epilim Chronosphere 1000mg prolonged-release granules 
Epilim Chronosphere 1000mg prolonged-release granules granule s produljenim oslobađanjem
Epilim Liquid 200mg/5ml 
Epilim Liquid 200mg/5ml oralna otopina
Depakine Chronosphere 100 mg, granulaat met gereguleerde afgifte 
Depakine Chronosphere 100 mg, granulaat met gereguleerde afgifte granule s prilagođenim oslobađanjem
Valproic acid Convulex 300 mg gastroresistant capsules, soft 
Convulex 300 mg gastroresistant capsules, soft želučanootporna kapsula, meka
Ergenyl Chronosphere 750 mg Retardgranulat 
Ergenyl Chronosphere 750 mg Retardgranulat granule s produljenim oslobađanjem
Ergenyl Chronosphere 250 mg Retardgranulat 
Ergenyl Chronosphere 250 mg Retardgranulat granule s produljenim oslobađanjem
400, poeder voor injectievloeistof 400 mg 
Depakine i.v. 400, poeder voor injectievloeistof 400 mg prašak i otapalo za otopinu za injekciju u venu
Valproic acid Convulex Capsules 150mg 150 mg 
Convulex Capsules 150mg 150 mg želučanootporna kapsula
103, Alexander Stamboliiski Blvd 1303 Sofia 
1303 Sofia
Depakine Chronosphere 250 mg, granulaat met gereguleerde afgifte 
Depakine Chronosphere 250 mg, granulaat met gereguleerde afgifte granule s prilagođenim oslobađanjem
Epilim Chronosphere MR 1000mg Modified Release Granules 
Epilim Chronosphere MR 1000mg Modified Release Granules granule s prilagođenim oslobađanjem
Valproic acid Convulex 150 mg gastroresistant capsules, soft 
Convulex 150 mg gastroresistant capsules, soft želučanootporna kapsula, meka
Ergenyl intravenös 
Ergenyl oralna otopina
Valproic acid Convulex 300 mg kapsuly 
Convulex 300 mg kapsuly kapsula
Depakine Chronosphere 500 mg, granulaat met gereguleerde afgifte 
Depakine Chronosphere 500 mg, granulaat met gereguleerde afgifte granule s prilagođenim oslobađanjem
Valproic acid Propymal Enteric 450 mg, maagsapresistente capsules 
Propymal Enteric 450 mg, maagsapresistente capsules želučanootporna kapsula
Epilim Chrono 500mg Controlled Release Tablets 
Epilim Chrono 500mg Controlled Release Tablets tableta s prilagođenim oslobađanjem
Ergenyl Chronosphere 100 mg Retardgranulat 
Ergenyl Chronosphere 100 mg Retardgranulat granule s produljenim oslobađanjem
Depakine Chronosphere 1000 mg - Retardgranulat in Beuteln 
Depakine Chronosphere 1000 mg - Retardgranulat in Beuteln granule s produljenim oslobađanjem
Valproic acid CONVULEX 300 mg gyomornedv-ellenálló lágy kapszula 
CONVULEX 300 mg gyomornedv-ellenálló lágy kapszula želučanootporna kapsula, meka
Coated tablet 
Delepsine tablet
Epilim Chronosphere 750mg prolonged-release granules 
Epilim Chronosphere 750mg prolonged-release granules granule s produljenim oslobađanjem
Valproic acid Convulex 500 mg kapsuly 
Convulex 500 mg kapsuly kapsula
Valproic acid Convulex 500 mg gastroresistant capsules, soft 
Convulex 500 mg gastroresistant capsules, soft želučanootporna kapsula, meka
Episenta 1000mg Prolongedrelease Granules 
Episenta 1000mg Prolongedrelease Granules granule s produljenim oslobađanjem
Natriumvalproaat chrono 300 mg Teva, tabletten met gereguleerde afgifte 
Natriumvalproaat chrono 300 mg Teva, tabletten met gereguleerde afgifte tableta s prilagođenim oslobađanjem
Valproic acid Propymal Enteric 600 mg, maagsapresistente capsules 
Propymal Enteric 600 mg, maagsapresistente capsules želučanootporna kapsula